Eastman Q4 adjusted EPS $0.75 vs $1.87 YoY; guides Q1 $1.00-$1.20

EASTMAN CHEMICAL CO

2025-FY EPS reported $4.10 vs consensus $0.73 ▲ beat (+463.5%)

Q4 2025 sales $1,973M (-12% YoY), adjusted EPS $0.75 vs $1.87 YoY.
Full-year 2025 adjusted EPS $5.42 vs $7.89; cash from ops ~$1B, down from $1.3B.
Cost reduction actions achieved ~$100M in savings; 2026 target $125M-$150M.
Kingsport methanolysis facility delivered ~$60M incremental earnings in 2025.
Q1 2026 adjusted EPS guidance $1.00-$1.20; no full-year EPS guidance due to macro uncertainty.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.